Results 71 to 80 of about 16,074 (250)

Evidence of complex involvement of serotonergic genes with restrictive and binge purge subtypes of anorexia nervosa [PDF]

, 2010
Peer ...
Blundell, John E., Bujac, Sarah R., Campbell, David A., Kiezebrink, Kirsty Margaret, Mann, Evleen T., Stubbins, Michael J.   +5 more
core   +1 more source

Microneedles for the treatment of migraine and orofacial pain: A narrative review

Headache: The Journal of Head and Face Pain, Volume 66, Issue 5, Page 1148-1161, May 2026.
Abstract Background Migraine is a common neurological disorder and a primary headache condition. Despite its central origin, migraine pain may be referred to the orofacial region via trigeminal pathways, resulting in phenotypic overlap with other orofacial pain (OFP) conditions.
Baicheng Cao, Qiuyi Chen, Yuhan Liu, Ruozhou Wu, Bin Li, Qing Cai, Lu Liu   +6 more
wiley   +1 more source

Post‐marketing safety of CGRP monoclonal antibodies and gepants: A systematic review of spontaneous reporting system data

Headache: The Journal of Head and Face Pain, Volume 66, Issue 5, Page 1128-1147, May 2026.
Abstract Objective Calcitonin gene‐related peptide (CGRP) inhibitors, including monoclonal antibodies (mAbs) and small‐molecule antagonists (gepants), have transformed migraine treatment. Although clinical trials established their efficacy and initial safety, post‐marketing surveillance is essential for understanding their real‐world safety profile in ...
Martina Giacon, Salvatore Terrazzino
wiley   +1 more source

Treatment resistant trigeminal neuralgia relieved with oral sumatriptan: a case report

Journal of Medical Case Reports, 2009
Introduction Treatment-resistant trigeminal neuralgia is a distressing condition, for both the patient and the treating doctor. To our knowledge, there are no reported cases of trigeminal neuralgia successfully treated with oral sumatriptan in the ...
Moran JA, Neligan A
doaj   +1 more source

Protective Effects of Lithium on Sumatriptan-Induced Memory Impairment in Mice

Acta Medica Iranica, 2016
Lithium is a drug used for the treatment of bipolar disorder. It has several mechanisms of action, and recently it is shown that lithium can antagonize the 5-HT1B/1D serotonin receptors.
Vahid Nikoui, Mehrak Javadi-Paydar, Mahtab Salehi, Selda Behestani, Ahmad Reza Dehpour   +4 more
doaj  

Drug-resistant chronic cluster headache successfully treated with supraorbital plus occipital nerve stimulation. A rare case report [PDF]

, 2015
Chronic cluster headache (CCH) is a rare and extremely disabling headache syndrome with a recent clinical systematization of its clinical frame from the European Headache Federation [1]. We present a case of a young man affected by drug-resistant chronic
Arcioni, Roberto, D'Alonzo, Lidia, Martelletti, Paolo, Mercieri, Marco, Negro, Andrea, Silvestri, Barbara, Tigano, Sara   +6 more
core   +1 more source

Ubrogepant Plasma and Cerebrospinal Fluid Exposures in Participants With a History of Migraine: Findings From a Phase 1b Open‐Label Trial

Clinical and Translational Science, Volume 19, Issue 4, April 2026.
ABSTRACT Ubrogepant (Ubrelvy), a CGRP receptor antagonist, is approved for acute treatment of migraine with or without aura in adults. Because ubrogepant treats a neurological condition, it is of interest to know central nervous system exposure. Ubrogepant concentrations in plasma and cerebrospinal fluid (CSF) were measured in participants with a ...
Ramesh R. Boinpally, Joel M. Trugman
wiley   +1 more source

Functional NHE1 expression is critical to blood brain barrier integrity and sumatriptan blood to brain uptake.

PLoS ONE, 2020
Disruption of blood-brain barrier integrity and dramatic failure of brain ion homeostasis including fluctuations of pH occurs during cortical spreading depression (CSD) events associated with several neurological disorders, including migraine with aura ...
Erika Liktor-Busa, Kiera T Blawn, Kathryn L Kellohen, Beth M Wiese, Vani Verkhovsky, Jared Wahl, Anjali Vivek, Seph M Palomino, Thomas P Davis, Todd W Vanderah, Tally M Largent-Milnes   +10 more
doaj   +1 more source

Migraine: Diagnosis, treatment and understanding c1960-2010 [PDF]

, 2014
seminar transcriptThere are around eight million migraine sufferers in the UK today. This Witness Seminar looked at the last 50 years of research into the diagnosis and treatment of the condition and the changing attitudes of the medical profession ...
Overy, C, Tansey, EM
core  

Rizatriptan versus rizatriptan plus rofecoxib versus rizatriptan plus tolfenamic acid in the acute treatment of migraine [PDF]

, 2004
Background Rizatriptan is an effective and fast acting drug for the acute treatment of migraine. Some nonsteroidal anti-inflammatory drugs (NSAID) have also demonstrated efficacy in treating migraine attacks.
Abouch Valenty Krymchantowski, Marcelo Eduardo Bigal, P Tfelt-Hansen, GD Solomon, G Gobel, GA Block, MD Ferrari, J Teall, P Tfelt-Hansen, H Gobel, RB Lipton, V Limmroth, AV Krymchantowski, P Tfelt-Hansen, AV Krymchantowski, AV Krymchantowski, AV Krymchantowski, JL Masferrer, MJ Langman, Headache Classification Subcommittee of the International Headache Society, MD Ferrari, S Silberstein, H Hakkarainen, J Parantainen, F Sheftell, K Saag, C Bombardier, L Mannix, V Myllyla, CA Bordini, SJ Peroutka, J Pascual   +31 more
core   +2 more sources